Treatment options for small cell lung cancer – do we have more choice?

Pemetrexed in Relapsed Small-Cell Lung Cancer and the Impact of Shortened Vitamin Supplementation Lead-In Time: Results of a Phase II Trial

(2010) Mark A. Socinski et al.   Journal of Thoracic Oncology

The New Lung Cancer Staging System

(2009) Frank C. Detterbeck et al.   CHEST

Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics

(2009) David R. Gandara et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer

(2009) John R. Eckardt et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124

(2009) Primo N. Lara et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer

(2009) Mark A. Socinski et al.   JOURNAL OF CLINICAL ONCOLOGY

Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial

(2009) Siow Ming Lee et al.   JNCI-Journal of the National Cancer Institute

CONVERT: Concurrent once-daily versus twice-daily radiotherapy – a new phase III randomised controlled trial for patients with limited-stage small cell lung cancer and good performance status

(2009) C. Faivre-Finn et al.   LUNG CANCER

Lung cancer screening: the way forward

(2008) J K Field et al.   BRITISH JOURNAL OF CANCER

Performance status and sensitivity to first-line chemotherapy are significant prognostic factors in patients with recurrent small cell lung cancer receiving second-line chemotherapy

(2008) Young Hak Kim et al.   CANCER

Radiotherapy in Extensive-disease Small Cell Lung Cancer. A Survey of Current UK Practice

(2008) N. Bayman et al.   CLINICAL ONCOLOGY

Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial

(2008) Andreas Hermes et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Phase II Study of Carboplatin and Etoposide With or Without thebcl-2Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

(2008) Charles M. Rudin et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402

(2008) Akira Inoue et al.   JOURNAL OF CLINICAL ONCOLOGY

A prospective phase II study: High-dose pemetrexed as second-line chemotherapy in small-cell lung cancer

(2008) Bjørn H. Grønberg et al.   LUNG CANCER

Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer

(2008) S M Lee et al.   THORAX

Phase II trial of thalidomide with chemotherapy and as maintenance therapy for patients with poor prognosis small-cell lung cancer

(2007) Siow Ming Lee et al.   LUNG CANCER